InfuSystem Holdings (INFU) Gains from Investment Securities (2010 - 2026)
InfuSystem Holdings (INFU) reported Gains from Investment Securities of -$563000.0 for Q1 2026, down 346.93% on a YoY basis from $228000.0 in Q1 2025, and up 51.04% quarter-over-quarter from -$1.2 million in Q4 2025.
InfuSystem Holdings (INFU) Gains from Investment Securities (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Gains from Investment Securities for 17 years, with the latest figure at -$563000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 346.93% year-over-year to -$563000.0; the trailing twelve-month figure through Mar 2026 stood at -$905000.0 (down 163.73% YoY), and the FY2025 full-year result was -$114000.0, down 113.97% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$563000.0, up from -$1.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.1 million in Q3 2025, with the low at -$1.3 million in Q2 2025.
- Historically, Gains from Investment Securities has averaged $146470.6 across 5 years, with a median of $70000.0 in 2022.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities jumped 6440.91% — and 2025, when it slumped 702.09%.
- InfuSystem Holdings' Gains from Investment Securities stood at $1.1 million in 2022, then tumbled by 203.8% to -$1.1 million in 2023, then soared by 116.67% to $191000.0 in 2024, then tumbled by 702.09% to -$1.2 million in 2025, then surged by 51.04% to -$563000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$563000.0 (Q1 2026), -$1.2 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -563,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | -1.33 Mn |
| Mar 31, 2025 | 228,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | -538,000.00 |
| Jun 30, 2024 | -538,000.00 |
| Mar 31, 2024 | -376,000.00 |
| Mar 31, 2024 | -376,000.00 |
| Dec 31, 2023 | -1.15 Mn |
| Dec 31, 2023 | -1.15 Mn |